SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001104659-24-073943
Filing Date
2024-06-21
Accepted
2024-06-21 16:18:13
Documents
1
Period of Report
2024-06-20

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT tm2417666-4_4seq1.html 4  
1 OWNERSHIP DOCUMENT tm2417666-4_4seq1.xml 4 5975
  Complete submission text file 0001104659-24-073943.txt   7436
Mailing Address MERRIMACK PHARMACEUTICALS, INC. ONE KENDALL SQUARE, SUITE B7201 CAMBRIDGE MA 02139
Business Address
Peters Richard (Reporting) CIK: 0001697628 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-39069 | Film No.: 241060435

Mailing Address 3805 OLD EASTON ROAD DOYLESTOWN PA 18902
Business Address 3805 OLD EASTON ROAD DOYLESTOWN PA 18902 617-463-9385
Aprea Therapeutics, Inc. (Issuer) CIK: 0001781983 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)